Navigation Links
Phase IV Multi-center Clinical Study of Kutai Concludes in Nanjing
Date:3/24/2009

sional team of clinical trial monitors as part of the project to keep close surveillance on the patients. The manager of Sinobiopharma's Clinical Research Department, Mr. Lei Wang, reported on the Phase IV project clinical monitoring outcomes.

The experts' consensus was that the Phase IV study established Kutai as safe and effective for room temperature storage. The year-long clinical research project showed no significant differences between Kutai and imported Cisatracurium besylate, and no significant differences for Kutai safety and effectiveness when stored at either room temperature or a lower temperature.

All the participating parties followed the study design and promote inter-communication to ensure compliance with Good Clinical Practice (GCP).

About Sinobiopharma

Sinobiopharma, Inc. is a fully integrated and highly innovative biotechnology company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world's fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co. Ltd. in China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs.

FORWARD LOOKING STATEMENTS

This news release may include "forward-looking statements" regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiopharma, Inc. expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which
'/>"/>

SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
2. Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes
3. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
4. Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
5. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
6. Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients
7. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
8. Walter Reed Army Medical Center offers HIFU for Qualifying Men with Locally Recurrent Prostate Cancer in a Phase III Clinical Trial
9. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
10. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
11. Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... received a patent acceptance notice from the Israeli patent ... to prevent or reduce tissue damage caused by an ... when cardiac vessels are opened after a blockage causing ... stroke victims. Damage can be caused to ...
(Date:3/26/2015)... March 26, 2015 InfuSystem Holdings, Inc. (NYSE MKT: ... services for the healthcare industry in the United ... today it has secured a new $45.0 million credit facility ... $36.5 million credit facility with its prior lender group.  ... the new five-year senior secured credit agreement comprised of a ...
(Date:3/26/2015)... 2015  Oxis Biotech, Inc. (OXIS), a ... [OTC: OXIS] and [Euronext Paris: OXI.PA] announced ... agreement with the University of Pittsburgh related ... Xiang-Qun Xie , Associate Dean for ... of Pharmacy.  These patents/intellectual properties relate to ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 2Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by the University of Pittsburgh 3
... 2010 Omnicell, Inc ., (Nasdaq: ... to acute healthcare facilities, will display its latest innovations ... (ASHP) Midyear Clinical Meeting and Exhibition from December ... previewed include the new Omnicell Savvy™ mobile medication system; ...
... is natural that all customers using the services of online ... for them and getting their order within the shortest possible ... and well-taken. This site assures new and regular clients with ... security. It uses the most updated methods to make every ...
Cached Medicine Technology:Omnicell to Showcase Latest Product Innovations at ASHP 2Omnicell to Showcase Latest Product Innovations at ASHP 3Omnicell to Showcase Latest Product Innovations at ASHP 4Omnicell to Showcase Latest Product Innovations at ASHP 5A New Online Pharmacy rxbuys.com by RX Corp Offers its Services to International Clients 2
(Date:3/26/2015)... (PRWEB) March 26, 2015 Visiting ... celebrate their 18th annual gala fundraiser, Lighting the Way, ... 6:30 p.m. at The Madison Hotel in Morristown, NJ. ... live entertainment by renowned musician Rio Clemente, delightful cuisine, ... Pat and Dave Hertzel. Additionally, two prestigious awards will ...
(Date:3/26/2015)... Calif. (PRWEB) March 26, 2015 Pacific ... repairs, is pleased to be featured on Innovations with ... on March 18, 2015. The episode will repeat ... is live on the Pacific Medical home page at: ... life threatening emergencies, it is reassuring to trust the ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... the Patients’ Access to Treatments Act (PATA) that ... week by Reps. David B. McKinley (R-WV) and ... limit cost-sharing requirements for medications placed in a ... by reducing patients’ out-of-pocket expenses. , This legislation ...
(Date:3/26/2015)... March 26, 2015 Leading nutritional ... state-of-the-art company website: http://www.metabolicnutrition.com . The ... website creates a user-friendly experience for consumers seeking ... , The new, enhanced Metabolic Nutrition website includes: ... the company’s diverse line of products, conveniently broken ...
(Date:3/26/2015)... The beauty industry united on Saturday, March ... revolutionized the business of beauty education. The Beauty Changes ... Pivot Point International, Inc. Passage’s wife Lenie, and son ... at the Art Institute of Chicago, the sold-out event ... media leaders and served as the signature gala event ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... Queensland is leading the way on research into ... medical use. , The National Institute of ... Professor Luis Vitetta to establish a NICM Collaborative ... Nutraceuticals and Herbal Medicine, which aims to support ...
... The American Red Cross,today launched Red Cross Racing, a ... and raise awareness of the need to give blood. ... fans are now able to join the Donor Rewards ... donation appointments,online. The site also offers frequent donors the ...
... Study of the Liver ... Annual Meeting -, SAN ... for the Study of the Liver,(EASL), the positive results of a Phase ... conducted by Dr. Edward,Gane, Associate Professor of Medicine, New Zealand Liver Transplant ...
... UK-based Association for International Cancer Research this week announced ... Dr Joe Tiralongo to further develop a potential anti-cancer ... , The grant will enable the team to ... in living cells. , Research leader Dr Joe Tiralongo ...
... surgeons to adjust suture tension during bridging procedures, ... SNN ; LSE: SN) Endoscopy Division today announced the ... to attach rotator cuff tissue to,bone in the shoulder. ... of North America (AANA) Spring Meeting, which began,today in ...
... Tool Helps Hospitals Assure That Their Computerized,Prescribing Systems ... in a National Hospital Quality Survey, WASHINGTON, ... Hospital Survey, The Leapfrog Group becomes the,first health ... hospitals to be,certain that their computerized medication prescribing ...
Cached Medicine News:Health News:UQ leads the way on complementary medicine research 2Health News:American Red Cross Launches New Interactive Website to Connect NASCAR Fans With Blood Donations 2Health News:Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R) 2Health News:Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R) 3Health News:$450,000 sweetener in colon cancer battle 2Health News:Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair 2Health News:Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair 3Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 2Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 3Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: